CSL: financial statements from SEC

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	5.02bn	5.00bn
Cost of revenue	3.23bn	3.12bn
Research and development	47m	35m
Selling, general and administrative	745m	723m
Operating income	1.00bn	1.14bn
Pre-tax income	949m	1.11bn
Income tax	206m	246m
Net income	741m	1.31bn
Earnings per share	17.27	28.17
Earnings per share, diluted	17.12	27.82
Weighted average shares	43m	47m
Weighted average shares, diluted	43m	47m

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	771m	1.11bn	1.11bn	68m	220m	754m	1.53bn	1.74bn
Receivables	692m	594m	774m	882m	699m	580m	799m	904m
Inventory	481m	447m	481m	501m	530m	473m	462m	426m
Current assets	2.03bn	2.28bn	2.48bn	1.53bn	1.53bn	1.93bn	2.91bn	3.15bn
Property, plant and equipment	813m	807m	783m	770m	738m	712m	671m	664m
Goodwill	1.54bn	1.54bn	1.53bn	1.54bn	1.49bn	1.48bn	1.34bn	1.34bn
Total assets	5.99bn	6.26bn	6.46bn	5.52bn	5.45bn	5.82bn	6.48bn	6.73bn
Current liabilities	601m	736m	765m	697m	593m	666m	1.07bn	1.09bn
Short-term debt	—	—	—	—	—	3m	403m	403m
Long-term debt	2.88bn	2.88bn	2.88bn	1.89bn	1.89bn	1.89bn	1.89bn	1.89bn
Equity	1.65bn	1.80bn	1.99bn	2.12bn	2.17bn	2.46bn	2.76bn	3.00bn
Shares outstanding	41m	41m	42m	43m	43m	44m	45m	46m
Treasury shares	38m	38m	37m	36m	35m	34m	33m	32m

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	1.10bn	1.03bn
Depreciation and amortisation	75m	70m
Share-based compensation	35m	30m
Capital expenditure	131m	113m
Investing cash flow	−240m	1.23bn
Dividends paid	181m	172m
Share buybacks	1.30bn	1.59bn
Financing cash flow	−504m	−2.11bn